Phio Pharmaceuticals Scraps Share Sale to Triton Funds

An update from Phio Pharmaceuticals (PHIO) is now available.

Phio Pharmaceuticals Corp. had an agreement to sell nearly 96,000 shares to Triton Funds LP, which could have brought in over $600,000 for Phio. However, when the stock’s price dropped below the agreed price, Phio backed out, deciding it was in their best interest to seek other financial options. No shares were exchanged before the deal was terminated, and this development was publicly announced in a recent press release.

Find detailed analytics on PHIO stock on TipRanks’ Stock Analysis page.